- Window Status: Open / Narrowing / Closing
- What Changed: Trajectory of evidence shifts
- What Holds: Stable evidence supporting the read
- What Is Under Stress: Contested evidence points
- What Would Reverse: Reversal conditions
NC // Decision Intelligence powered by Claim Forensics
Disputed healthcare claim under review?
Identify evidence stabilization 100–400 days before institutional action. Get source-backed intelligence showing what changed, what holds, and what moves the needle.
NextConsensus produces high-discipline decision briefs for coverage, regulatory, safety, and diligence reviews. Delivered as a 1-page, auditable specimen.
Public lane note
finerenone / albuminuric CKDLive Inventory
Hardened Evidence Lanes
02 // THE OUTPUT
A disciplined, falsifiable decision memo.
The brief is the core product. It is built for teams that need to make decisions while the evidence record is still moving.
03 // YOUR CONTEXT
Built for five review contexts.
NextConsensus indexes evidence shifts by decision triggers, identifying which changes materially change the read for specific review types.
Payer policy, Medicaid, and coverage determination reviews
P&T committee dockets and formulary exclusion challenges
FDA label updates, briefing documents, and advisory meetings
Safety communications, risk management, and signal surveillance
Asset valuation, licensing, and pre-acquisition evidence audits
04 // THE TIMING
Evidence moves before institutions act.
We track the mismatch between evidence movement and institutional timing. In drug safety, regulatory, and coverage reviews, the record often stabilizes months before the formal recognition event.
"What would reverse the read?" We identify the specific evidence shifts that would materially change the conclusion.
Capture generic entry signals 90+ days early, optimize formulary submission timing, or detect safety signals before they hit the headlines.
Validated Specimens
Proven Lead Times
Independent out-of-sample audits confirm evidence stabilization precedes institutional action by 100 to 400 days.
Signal detected absence of change (hardening) 3 months before outcome.
Hardening spike triggered by concentrated clinical data stabilization.
Stabilized consensus detected 1 year before broad institutional recognition.
05 // TRUST ARCHITECTURE
Restraint is a feature.
The validation boundary is part of the product. We do not predict outcomes. We do not promote unsupported claims. If the evidence is not strong enough to support a read, the brief says so plainly.
We do not predict institutional outcomes. We provide the source-backed record so your team can make the call with zero hallucination risk.
Public numeric claims remain frozen until production backtest gates are cleared. Private briefs carry explicit lineage and caveats.
Every read is linked to a specific versioned measurement artifact and source snapshot.
Start
Have one claim, one review date?
We still have time to make a better call — but not indefinitely. Send the claim, the decision context, and the review date. We respond within one business day with fit, limits, and next steps.
Requests for sourced specimens require a verified institutional email address and are subject to the current lane authorization limits.